Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H16N2O3S.H2O |
Molecular Weight | 274.337 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.CC1=CC(=C(C=C1)N2CCNCC2)S(O)(=O)=O
InChI
InChIKey=ZRQKZWAOIRVBFD-UHFFFAOYSA-N
InChI=1S/C11H16N2O3S.H2O/c1-9-2-3-10(11(8-9)17(14,15)16)13-6-4-12-5-7-13;/h2-3,8,12H,4-7H2,1H3,(H,14,15,16);1H2
Caldaret is intracardiac calcium (Ca2+) handling modulator whose cardioprotective actions are presumed to be due to inhibition of the NCX exchanger and increasing the uptake of Ca2+ via the sarcoplasmic reticulum (SR). Unfortunately, Caldaret failed to demonstrate efficacy in Phase II clinical trials as an adjunct to standard therapy with primary percutaneous coronary intervention patients diagnosed as having an acute myocardial infarction
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00078013
4.5 mg/kg/48 hours
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID20431256
Created by
admin on Fri Dec 15 15:49:11 GMT 2023 , Edited by admin on Fri Dec 15 15:49:11 GMT 2023
|
PRIMARY | |||
|
DBSALT002435
Created by
admin on Fri Dec 15 15:49:11 GMT 2023 , Edited by admin on Fri Dec 15 15:49:11 GMT 2023
|
PRIMARY | |||
|
192509-24-3
Created by
admin on Fri Dec 15 15:49:11 GMT 2023 , Edited by admin on Fri Dec 15 15:49:11 GMT 2023
|
PRIMARY | |||
|
2SH110E854
Created by
admin on Fri Dec 15 15:49:11 GMT 2023 , Edited by admin on Fri Dec 15 15:49:11 GMT 2023
|
PRIMARY | |||
|
9816981
Created by
admin on Fri Dec 15 15:49:11 GMT 2023 , Edited by admin on Fri Dec 15 15:49:11 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD